Primate Testing Still Vital say CROs After NIH Pledge To Reduce Chimp Use
Primate research is still vital to drug development say CROs after US NIH announces plan to reduce the number of chimps it uses in preclinical testing.
Primate research is still vital to drug development say CROs after US NIH announces plan to reduce the number of chimps it uses in preclinical testing.
Correction
After patent expiration led to facility shuttering and cutbacks, Irish manufacturing will receive a $130m (€100m) boost to prepare for Pfizer’s new pipeline, the company says.